Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Vorolanib |
Trade Name | |
Synonyms | X-82|CM-082|CM082 |
Drug Descriptions |
Vorolanib (X-82) is a dual VEGFR/PDGFR inhibitor, which inhibits tumor angiogenesis and cell proliferation in tumors (PMID: 32335374, PMID: 30478190). |
DrugClasses | PDGFR Inhibitor (Pan) 30 VEGFR Inhibitor (Pan) 36 |
CAS Registry Number | 1013920-15-4 |
NCIT ID | C95896 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atezolizumab + Vorolanib | Atezolizumab Vorolanib | 0 | 1 |
Docetaxel + Vorolanib | Docetaxel Vorolanib | 0 | 1 |
Everolimus + Vorolanib | Everolimus Vorolanib | 0 | 1 |
Nivolumab + Vorolanib | Nivolumab Vorolanib | 0 | 2 |
Pembrolizumab + Vorolanib | Pembrolizumab Vorolanib | 0 | 1 |
Vorolanib | Vorolanib | 0 | 1 |